Ching-Hwa Sung

Title: Ching-Hwa Sung: Innovator in Neural Progenitor Cell Research

Introduction

Ching-Hwa Sung is a notable inventor based in New York, NY (US). He has made significant contributions to the field of stem cell research, holding a total of 3 patents. His work focuses on innovative methods for manipulating and identifying neural progenitor and stem cells.

Latest Patents

One of his latest patents is titled "Tctex-1 regulatory sequence as stem cell marker." This patent discloses an isolated regulatory sequence for Tctex-1 that is transcriptionally active in adult neural progenitor and stem cells, including Type 1, Type 2, and Type 3 progenitors, as well as during development. The patent also outlines a method for selectively expressing a genetic sequence in neural progenitor cells. This innovation allows for the marking, identification, sorting, tracking, and manipulation of neural progenitor and stem cells.

Another significant patent is "Stimulating neurite outgrowth using Tctex-1-related polypeptides." This patent describes a method of stimulating neurite outgrowth in a subject by administering a formulation that includes a Tctex-1-related polypeptide. This polypeptide has been shown to effectively stimulate neurite outgrowth in vitro.

Career Highlights

Ching-Hwa Sung has worked with esteemed institutions such as the Cornell Research Foundation Inc. and Cornell University. His research has contributed to advancements in understanding neural progenitor cells and their applications in regenerative medicine.

Collaborations

Throughout his career, Ching-Hwa Sung has collaborated with notable colleagues, including Jen-Zen Chuang and Rajiv R Ratan. These collaborations have further enriched his research and innovations in the field.

Conclusion

Ching-Hwa Sung's contributions to stem cell research and his innovative patents highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in neural progenitor cell manipulation and understanding.